Devyser SRL
3.0 FTEThe score of Devyser shows with a free account.
See the score- Summary? / 5
- Solvency
- Liquidity
- Interest coverage
- Profitability
- Leverage
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +527 % Total assets +3 % Headcount (avg FTE) +50 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Devyser's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 11 May 2026
- Year ended 31 Dec 2024filed on 12 Jun 2025
- Year ended 31 Dec 2023filed on 10 Jul 2024
- Year ended 31 Dec 2022filed on 29 Jun 2023
Devyser's financial analysis
- Solvency55.7%sector median: 40.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Devyser
Devyser's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0783.330.626
- VAT number
- BE0783330626
- Peppol
- Registered · 0208:0783330626 · as of 18 Oct 2026
- Legal form
- SRL
- Incorporated
- 11 Mar 2022
- Registered office
- 1000 Brussels
- Size
- Micro · 3.0 FTE
- Latest accounts
- 2025 · filed on 11 May 2026
- Activity
- Manufacture of irradiation, electromedical and electrotherapeutic equipment (NACE 26600)
Devyser (SRL) has been based in Brussels since 2022, active in: manufacture of irradiation, electromedical and electrotherapeutic equipment. For 2025, it reports a net profit of 36,407 € and equity of 250,595 €; its revenue is not published. With 3.0 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 55.7%, above the median of its sector (40.8%).
Companies similar to Devyser
Companies in the same business, of comparable size and area, outside its group.
- Compagnie Internationale DE Distribution Wholesale of pharmaceutical and medical goods Uccle · balance sheet 517,231 €
- De Ceunynck Radiotherapy Manufacture of pharmaceutical preparations Aartselaar · balance sheet 635,020 €
- Codema Wholesale of pharmaceutical and medical goods Lokeren · balance sheet €1.16m
- Vita Nova Supra Wholesale of pharmaceutical and medical goods Beringen · balance sheet €1.80m
- BM 2 Consulting Wholesale of pharmaceutical and medical goods Beersel · balance sheet 207,573 €
- Devroye Instruments Wholesale of pharmaceutical and medical goods Etterbeek · balance sheet €1.70m
- Medical Electronic Systems Europe Wholesale of pharmaceutical and medical goods Fleurus · balance sheet 776,419 €
- CorQuest MedTech Manufacture of irradiation, electromedical and electrotherapeutic equipment Namur · balance sheet 675,137 €
Frequently asked questions about Devyser
What is the revenue of Devyser?
Devyser files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Devyser?
In Belgium, the VAT number is the company number prefixed with BE: BE0783330626 for Devyser, if the company is VAT-registered. Its company number (CBE) is 0783.330.626.
Where is the registered office of Devyser?
According to the CBE register, the registered office of Devyser is in 1000 Brussels.
What is the equity of Devyser?
At the close of the 2025 financial year, the equity of Devyser amounts to 250,595 €, a solvency of 55.7% of total assets.
How many people work at Devyser?
3.0 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Devyser?
The register lists 2 active mandates at Devyser. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Devyser
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →